Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cinnovex versus Avonex Clinical Trial
IRCT138711281696N1Phase 3Completed
- Sponsor
- CinnaGen
- Start
- Aug 2006
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of cinnarizine + dimenhydrinate, interferon beta-1a in multiple sclerosis (MS), sponsored by CinnaGen. Started Aug 2006; status: completed.
02
Drugs
cinnarizine + dimenhydrinateinterferon beta-1a
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on IRCT138711281696N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT138711281696N1.